|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2010-10-28
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
The expression of vascular endothelial growth factor (VEGF) is elevated in diabetic macular edema (DME). Ranibizumab binds to and inhibits multiple VEGF variants. We investigated the safety and efficacy of ranibizumab in DME involving the foveal center.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1935-5548
|
|
pubmed:author |
pubmed-author:BandelloFrancescoF,
pubmed-author:GarwegJustus GJG,
pubmed-author:GekkievaMargaritaM,
pubmed-author:HansenLutz LLL,
pubmed-author:HardingSimon PSP,
pubmed-author:LarsenMichaelM,
pubmed-author:MassinPascaleP,
pubmed-author:MitchellPaulP,
pubmed-author:SharpDianneD,
pubmed-author:WeichselbergerAndreasA,
pubmed-author:Wolf-SchnurrbuschU E KUE,
pubmed-author:WolfSebastianS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
33
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2399-405
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20980427-Adult,
pubmed-meshheading:20980427-Aged,
pubmed-meshheading:20980427-Aged, 80 and over,
pubmed-meshheading:20980427-Antibodies, Monoclonal,
pubmed-meshheading:20980427-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:20980427-Diabetic Retinopathy,
pubmed-meshheading:20980427-Female,
pubmed-meshheading:20980427-Humans,
pubmed-meshheading:20980427-Macular Edema,
pubmed-meshheading:20980427-Male,
pubmed-meshheading:20980427-Middle Aged,
pubmed-meshheading:20980427-Treatment Outcome
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study.
|
|
pubmed:affiliation |
Assistance Publique des Hôpitaux de Paris, Ophthalmology Department, Hôpital Lariboisièe, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase II
|
